Live feed17:13:24·497dINSIDERFilingvia QuantisnowPresident, Head of R&D Gallagher Neil sold $71,597 worth of shares (4,618 units at $15.50), decreasing direct ownership by 5% to 85,095 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.SNDX· Syndax Pharmaceuticals Inc.Health CareOriginal source